Drug Prices Under Renewed Pressure In 2012-13May 2012 | Industry Trend Analysis
BMI View: While the recently appointed new heads at the Bulgarian Ministry of Health and the National Health Insurance Fund (NHIF) are now clearly looking at more aggressive mechanisms for cutting drug prices in the country, despite the short-term challenges we still believe the market is attractive and will generate high single-digit yearly growth over our five-year forecast period. Our 2012-2013 forecast scenario for Bulgaria's pharmaceutical market is governed by two main factors. Namely, short-term negotiations of medicine price cuts and the likelihood that the health ministry and the NHIF will push ahead with more far-reaching legislative changes to how Bulgaria prices its medicines.
To read the full article, please choose one of the following options: